Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BioFire COVID-19 Test 2

K-Number: K221460 · 2022-07-25

Decision Date2022-07-25
Product CodeQQX
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

BioFire COVID-19 Test 2 is a medical device manufactured by Biofire Defense, LLC. It received FDA 510(k) clearance on 2022-07-25 under approval number K221460. The device is classified under product code QQX. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BioFire COVID-19 Test 2?

BioFire COVID-19 Test 2 is a medical device that received FDA 510(k) clearance on 2022-07-25. It is manufactured by Biofire Defense, LLC. The 510(k) number is K221460.

When was BioFire COVID-19 Test 2 approved by the FDA?

BioFire COVID-19 Test 2 received FDA 510(k) clearance on 2022-07-25, under approval number K221460.

What company makes BioFire COVID-19 Test 2?

BioFire COVID-19 Test 2 is manufactured by Biofire Defense, LLC.

What is the FDA product code for BioFire COVID-19 Test 2?

The FDA product code for BioFire COVID-19 Test 2 is QQX.

Other Devices by Biofire Defense, LLC

View all 9 devices →

Related Devices (Code: QQX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.